Reaktionsgleichung
[O:1]=[C:2]1[CH:6]([C:7]2[CH:12]=[CH:11][C:10]([C:13]([F:16])([F:15])[F:14])=[CH:9][CH:8]=2)[CH2:5][CH2:4][N:3]1[CH2:17][C:18]([OH:20])=O.FC1C=CC(C2(C3C=CC(F)=CC=3)CCCN(CC(O)=O)C2=O)=CC=1.[F:46][C:47]([F:58])([F:57])[C:48]1[CH:49]=[C:50]2[C:54](=[CH:55][CH:56]=1)[CH2:53][NH:52][CH2:51]2.C1(C2(C3C=CC=CC=3)CCNC2)C=CC=CC=1>>[O:20]=[C:18]([N:52]1[CH2:51][C:50]2[C:54](=[CH:55][CH:56]=[C:48]([C:47]([F:46])([F:58])[F:57])[CH:49]=2)[CH2:53]1)[CH2:17][N:3]1[CH2:4][CH2:5][CH:6]([C:7]2[CH:12]=[CH:11][C:10]([C:13]([F:16])([F:14])[F:15])=[CH:9][CH:8]=2)[C:2]1=[O:1]Komponenten
5
Versuchsvorschrift
The title compound was prepared using the procedure described in Example 172 substituting 2-(2-oxo-3-(4-(trifluoromethyl)phenyl)pyrrolidin-1-yl)acetic acid from Example 266D for 2-(3,3-bis(4-fluorophenyl)-2-oxopiperidin-1-yl)acetic acid and 5-(trifluoromethyl)isoindoline for 3,3-diphenylpyrrolidine. 1H NMR (300 MHz, CDCl3) δ ppm 7.58 (t, J=12.0, 4H), 7.42 (dd, J=8.2, 20.4, 3H), 4.91 (d, J=16.7, 4H), 4.23 (dd, J=16.2, 36.5, 2H), 3.83 (t, J=8.3, 1H), 3.77-3.62 (m, 2H), 2.74-2.54 (m, 1H), 2.32-2.16 (m, 1H); MS (DCI) m/z 457.1 (M+H)+.
Quellen und Nachweise
- ORD-Eintrag
- ord-c54dc7bb4beb40998e1441dfafdcd26b
- Quelldatensatz
- uspto-grants-2011_10
- Patentnummer
- US08044069B2
Verknüpfte Notizen
Wird geladen…